Aurinia Pharmaceuticals Inc (AUPH)
8.86
+0.09
(+1.03%)
USD |
NASDAQ |
Nov 22, 16:00
8.88
+0.02
(+0.23%)
Pre-Market: 20:00
Aurinia Pharmaceuticals Price: 8.86 for Nov. 22, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 22, 2024 | 8.75 | 9.04 | 8.65 | 8.86 | 1.596M |
Nov 21, 2024 | 8.311 | 8.83 | 8.30 | 8.77 | 2.417M |
Nov 20, 2024 | 8.07 | 8.26 | 7.91 | 8.24 | 1.274M |
Nov 19, 2024 | 7.95 | 8.14 | 7.89 | 8.13 | 1.261M |
Nov 18, 2024 | 8.13 | 8.14 | 7.87 | 8.01 | 1.196M |
Nov 15, 2024 | 8.36 | 8.39 | 8.07 | 8.12 | 1.445M |
Nov 14, 2024 | 8.33 | 8.41 | 8.10 | 8.33 | 1.406M |
Nov 13, 2024 | 8.43 | 8.48 | 8.06 | 8.28 | 1.579M |
Nov 12, 2024 | 8.45 | 8.58 | 8.275 | 8.38 | 1.552M |
Nov 11, 2024 | 8.29 | 8.701 | 8.29 | 8.49 | 1.961M |
Nov 08, 2024 | 8.39 | 8.40 | 7.98 | 8.32 | 2.230M |
Nov 07, 2024 | 7.84 | 8.74 | 7.80 | 8.34 | 4.246M |
Nov 06, 2024 | 7.45 | 7.565 | 7.32 | 7.52 | 1.651M |
Nov 05, 2024 | 7.17 | 7.35 | 7.09 | 7.32 | 962206.0 |
Nov 04, 2024 | 7.28 | 7.28 | 7.03 | 7.21 | 1.197M |
Nov 01, 2024 | 7.20 | 7.37 | 7.16 | 7.32 | 821000.0 |
Oct 31, 2024 | 7.37 | 7.39 | 7.21 | 7.21 | 825181.0 |
Oct 30, 2024 | 7.48 | 7.485 | 7.325 | 7.36 | 891731.0 |
Oct 29, 2024 | 7.21 | 7.50 | 7.18 | 7.49 | 1.037M |
Oct 28, 2024 | 7.12 | 7.32 | 7.09 | 7.24 | 1.072M |
Oct 25, 2024 | 7.05 | 7.18 | 6.996 | 7.05 | 808715.0 |
Oct 24, 2024 | 7.02 | 7.075 | 6.94 | 7.04 | 622244.0 |
Oct 23, 2024 | 7.04 | 7.05 | 6.85 | 6.99 | 812003.0 |
Oct 22, 2024 | 7.13 | 7.16 | 7.00 | 7.07 | 530384.0 |
Oct 21, 2024 | 7.03 | 7.20 | 6.940 | 7.17 | 1.020M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.11
Minimum
Dec 27 2022
33.08
Maximum
Oct 29 2021
11.85
Average
11.22
Median
Price Benchmarks
Edesa Biotech Inc | 2.17 |
Lexaria Bioscience Corp | 2.09 |
Xenon Pharmaceuticals Inc | 41.15 |
ESSA Pharma Inc | 1.83 |
ImmunoPrecise Antibodies Ltd | 0.376 |
Price Related Metrics
PS Ratio | 5.804 |
Price to Book Value | 3.270 |
Price to Free Cash Flow | 45.19 |
Earnings Yield | -1.58% |
Market Cap | 1.269B |